Over the past decade, advances in molecular biology and genomics techniques have revolutionized the diagnosis and treatment of cancer. The technological advances in tissue profiling have also been applied to the study of cell-free nucleic acids, an area of increasing interest for molecular pathology. Cell-free nucleic acids are released from tumour cells into the surrounding body fluids and can be assayed non-invasively. The repertoire of genomic alterations in circulating tumour DNA (ctDNA) is reflective of both primary tumours and distant metastatic sites, and ctDNA can be sampled multiple times, thereby overcoming the limitations of the analysis of single biopsies. Furthermore, ctDNA can be sampled regularly to monitor response to treatm...
With the addition of molecular testing to the oncologist’s diagnostic toolbox, patients have benefit...
Abstract: Qualitative and quantitative testing of circulating cell free DNA (CCFDNA) can be applied ...
The increasing knowledge of the molecular pathogenesis of cancer and the rapid development of new mo...
The aim of this review is to evaluate the present status of the use of cell-free DNA and its fractio...
Translational research of liquid biopsy is just at the edge of routine clinical application: an emer...
Recently, many genome-wide profiling studies provided insights into the molecular make-up of major c...
changed the treatment of cancer over the past 10 years. However, almost all tumors acquire resistanc...
Precision medicine in the clinical management of cancer may be achieved through the diagnostic platf...
Detection of circulating tumor DNAs (ctDNAs) in cancer patients is an important component of cancer ...
Introduction: Although the role of circulating cell free DNA in cancer has been widely demonstrated,...
Circulating cell-free DNA (cfDNA) is DNA released from necrotic or apoptotic cells into the bloodstr...
During cancer progression and treatment, multiple subclonal populations of tumour cells compete with...
Yi Chang,1,2,* Bhairavi Tolani,2,* Xiuhong Nie,1 Xiuyi Zhi,3 Mu Hu,3 Biao He2 1Department of Respir...
Abstract: With the development of new sensitive molecular techniques, circulating cell-free tumour D...
Improvements in genomic and molecular methods are expanding the range of potential applications for ...
With the addition of molecular testing to the oncologist’s diagnostic toolbox, patients have benefit...
Abstract: Qualitative and quantitative testing of circulating cell free DNA (CCFDNA) can be applied ...
The increasing knowledge of the molecular pathogenesis of cancer and the rapid development of new mo...
The aim of this review is to evaluate the present status of the use of cell-free DNA and its fractio...
Translational research of liquid biopsy is just at the edge of routine clinical application: an emer...
Recently, many genome-wide profiling studies provided insights into the molecular make-up of major c...
changed the treatment of cancer over the past 10 years. However, almost all tumors acquire resistanc...
Precision medicine in the clinical management of cancer may be achieved through the diagnostic platf...
Detection of circulating tumor DNAs (ctDNAs) in cancer patients is an important component of cancer ...
Introduction: Although the role of circulating cell free DNA in cancer has been widely demonstrated,...
Circulating cell-free DNA (cfDNA) is DNA released from necrotic or apoptotic cells into the bloodstr...
During cancer progression and treatment, multiple subclonal populations of tumour cells compete with...
Yi Chang,1,2,* Bhairavi Tolani,2,* Xiuhong Nie,1 Xiuyi Zhi,3 Mu Hu,3 Biao He2 1Department of Respir...
Abstract: With the development of new sensitive molecular techniques, circulating cell-free tumour D...
Improvements in genomic and molecular methods are expanding the range of potential applications for ...
With the addition of molecular testing to the oncologist’s diagnostic toolbox, patients have benefit...
Abstract: Qualitative and quantitative testing of circulating cell free DNA (CCFDNA) can be applied ...
The increasing knowledge of the molecular pathogenesis of cancer and the rapid development of new mo...